Mereo BioPharma (MREO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.32 -3.03%
EPS Growth %: +50.0%
Financial Fact:
Total cost of sales: 77.87K
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +50.0%
Financial Fact:
Total cost of sales: 77.87K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Lockheed Martin wins $8.4B missile contract modification
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
